Kaimin Chan

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung et al. · Nature Medicine · 2022 · 374 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera

Ranawaka A. P. M. Perera, Ronald LW Ko, Owen TY Tsang et al. · Journal of Clinical Microbiology · 2020 · 136 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +11

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents

Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung et al. · Nature Communications · 2022 · 69 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial

Nancy Leung, Samuel M. S. Cheng, Carolyn A. Cohen et al. · The Lancet Microbe · 2023 · 25 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine

Nancy Leung, Samuel M. S. Cheng, Mario Martín-Sánchez et al. · Clinical Infectious Diseases · 2022 · 18 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17